Inventor · disambiguated record
Fang Shen
Also filed as: SHEN FANG · SHEN FANG-CHING
7 granted patents·6 pending applications·20 citations·filing 2003–2022
78Inventor score
Files withJANSSEN BIOTECH INC3JANSSEN PHARMACEUTICA NV3GAFFEN SARAH L2HOFFMANN LA ROCHE2HUANG WENYA1
Top patents by PatentIndex Score
13 records- 0192US10596173B2Combination therapy of an HBV capsid assembly inhibitor and an interferonHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·10 cites·25 claims
- 0290US10954214B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 23, 2021·5 cites·37 claims
- 0376US11040031B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 22, 2021·2 cites·9 claims
- 0470US8460647B2Pre-ligand assembly domain of the IL-17 receptorGAFFEN SARAH L·Filed 2008·Granted Jun 11, 2013·3 cites·8 claims
- 0564US12077521B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 0656US8293474B2Oligonucleotides and use thereof for determining deletion in HBV Pre-S regionHUANG WENYA·Filed 2009·Granted Oct 23, 2012·0 cites·8 claims
- 0756US2020276198A1Combination therapy of an hbv capsid assembly inhibitor and an interferonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0855US2020010571A1Bispecific Anti-TNF-Alpha/IL-17A Antibodies and Anti-TNF-Alpha Antibodies and Methods of Their UseJANSSEN BIOTECH INC·Filed 2019·Application pending·0 cites
- 0951US2024158499A1Uses of cd79b antibodies for autoimmune therapeutic applicationsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1050US2024174741A1Il-38-specific antibodiesIMMUNOME INC·Filed 2022·Application pending·0 cites
- 1147US2017218092A1Bispecific Anti-TNF-Alpha/IL17A Antibodies and Anti-TNF-Alpha Antibodies and Methods of Their UseJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 1240US2013302886A1Pre-Ligand assembly domain of the IL-17 receptorGAFFEN SARAH L·Filed 2013·Application pending·0 cites
- 1325US7112605B2Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereofJIANGSU HENGRUI MEDICINE COMPA·Filed 2003·Granted Sep 26, 2006·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Fang Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →